Tom Winnifrith Bearcast - No Roger don't close down the fraudbusters please support investigative journalists not a failed establishment
Published 6 days ago
It is the house broker so not impartial. I think the target for Premaitha (NIPT) is too low and bought more shares this morning in the secondary market. But here is the Finncap take in a 20 page note:
Published 115 days ago
Updating on Premaitha Health (NIPT) earlier in the week we noted an up to £2.1 million loan facility agreement to fund costs related to the ongoing Illumina litigation and that a Form of Order hearing is scheduled to take place early this week. The shares are currently rising towards 5p on the back of a UK High Court grants right to appeal announcement from the company…
Published 177 days ago
After the Illumina legal setback for Premaitha (NIPT) we suggested that the cost of that setback was very manageable – a maximum of less than £2 million is what we hear – and that the underlying business is doing very well. That view is reaffirmed by latest news.
Published 180 days ago
This is not the news we Premaitha (NIPT) shareholders wanted and it is clearly bad news. The question is how bad? The UK High Court has upheld three patent claims made by Illumina against Premaitha.
Published 258 days ago
Premaitha (NIPT) has announced that it has been approved for Brazilian Good Manufacturing Practice for the company's IONA test by Brazil's regulatory authority, the Agência Nacional de Vigilância Sanitária. Jolly good news and it strengthens the story, but it is not the elephant in the room is it?
Published 309 days ago
Premaitha Health (NIPT) has announced that it has entered into a further extension of the investment agreement with Thermo Fisher Scientific announced on 14 December 2015 and extended as announced on 23 September 2016. This is good news.
Published 318 days ago
And so after more than a year of huff and puff and fascist corporate bullying by US giant Illumina, the High Court action with Premaitha (NIPT) starts tomorrow. Premaitha says:
Published 346 days ago
Premaitha (NIPT) has updated investors on its progress in India where it claims now to have representation in 9 of the 15 most populous states with several of the largest nationwide pathology laboratory groups running Yourgene's NIPT workflow in-house.
Published 368 days ago
Premaitha (NIPT) has updated on trading in the year to March 31 2017. Of course, what matters is not historic trading but the future, that is to say the patent challenge by US corporate fascist bully-boys Ilumina. However, some numbers do matter...
Published 373 days ago
The issue with Genoma was flagged up in the interims pre-Christmas. It owes Premaitha (NIPT) £750,000. That debt looks like a bad debt because the Swiss company has - despite its parent company concluding a fundraise - been having financial issues. So Premaitha has gone to court and had Genoma made bankrupt.
Published 589 days ago
Premaitha (NIPT) announced late last week its results for the year to March 31 2016. Given the pace of events here these historic numbers do not mean that much but for the record:
Published 601 days ago
Apologies for the delay in commenting on this RNS which landed on Friday. We wanted to speak to Adam Reynolds and we have now done so. This is just the start of the good news and ahead of results tomorrow Premaitha (NIPT) shares are a buy.
Published 679 days ago
After 44 years of membership, at last one good thing has come out of the EU for Britain. God bless the Evil Empire. Premaitha (NIPT) has provided an update on its legal battles with US bully boys Illumina.
Published 759 days ago
Although the twit who handles PR for Premaitha (NIPT) has again contrived to confuse the issue with some garbled press releases this morning there is actually some good news. Fire the idiot PR man and investors could get excited as they discover what is really going on.
Published 767 days ago
The shares of Premaitha (NIPT) have been all over the shop since what was a cracking year end trading statement on Monday. The reason is the cackhanded disposal of Rupert Lywood's remaining 17.9% stake. We thought he was locked in following his last dump on 9 March and a statement signed off by broker Finncap. Weasel words. His shares were placed by Finncap at just 6.5p with directors taking some and solid institutions Helium, Henderson and Hargreave Hale taking the rest. The overhang is now gone but boy has it crushed the shares. Without Lywood's "assistance" since last summer we think the shares would be 20p today. But he is now out of the picture.
Published 840 days ago
Premaitha Health (NIPT) has announced further international expansion of its customer base and updated on UK litigation timing
Published 862 days ago
Premaitha Health (NIPT) has noted an announcement from Illumina, Inc. of patent infringement suits against Premaitha's customer in Poland and Ariosa Diagnostics, a subsidiary of Roche, and their customer, The Doctors Laboratory, in the UK, while reiterating that it “continues to make a robust defence against earlier claims by Illumina and the board is confident that the IONA test does not infringe the patents as claimed in the earlier cases or in relation to today's announcement”
Published 868 days ago
Ok this was one of my less successful share tips of the year for 2015 but this time it really will come good. That will be the prompt for guffaws of laughter from Wildes, who is currently sitting on a sinking lifeboat from the doomed SS LGO Energy. But he who laughs last...
Published 953 days ago
Premaitha Health (NIPT) has announced an agreement with the leading distributor of scientific products in Greece (Antisel SA) to provide its IONA test to clinical laboratories in the region and that it has been informed that American company Illumina, Inc. has added a third patent to its suit against it. Buy, sell or hold?